[Highlights and interpretation of the 2025 European Respiratory Society clinical practice guideline for the management of adult bronchiectasis].
Abstract
infection and frequent exacerbations. Eradication therapy and the use of mucoactive agents are conditionally recommended in certain cases. Routine long-term use of non-macrolide oral antibiotics or inhaled corticosteroids is not recommended. In addition, the guideline provides updated recommendations on etiological evaluation, acute exacerbation management, and the care of patients with disease progression. This article aims to systematically interpret the core updates of the new ERS guideline, compare them with previous versions, and offer insights for improving the clinical management of adult bronchiectasis in China.
Fields of Study & Subjects
Cystic Fibrosis Research Advances
Chronic Obstructive Pulmonary Disease (COPD) Research
Clinical practice guidelines implementation
Publication details
- Journal / source
- PubMed
- Volume
- 49
- Issue
- 2
- Pages
- 150–157
- Publication date
- 12 February 2026
- Language
- ZH